Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis Here are the key points from the research article on rivaroxaban vs standard-of-care for cerebral venous thrombosis (CVT): - The study was a randomized controlled feasibility trial conducted at 12 Canadian centers comparing rivaroxaban to standard anticoagulation (warfarin or low molecular weight heparin) for CVT. - 55 participants were enrolled over 2.5 years. The recruitment rate was 21.3 participants per year, meeting feasibility targets. 57% of eligible patients consented to enroll. - Median age was 48 years and 66% were fem ...